Industry Alert: Forged Test

FSC has been alerted that a performer previously using the stage name Zae Eden attempted to work using a forged test, digitally manipulated in PDF form. The fraud was discovered when another performer attempted to verify the test in the PASS database. We are now aware...

FSC-PASS To Add New Testing Network, AIT, Beginning April 2

FSC announces the addition of a new testing network, Adult Industry Testing (AIT), to the PASS system, beginning April 2, 2019. AIT will begin with six locations in the Los Angeles area, including two in Woodland Hills, and one each in Mission Hills, Burbank, Beverly...

FSC Board Statement on HIV, PASS and The Antibody Test

Over the last two months, there have been confusing claims and counterclaims made regarding PASS in social media, the press, and at industry trade shows. The Free Speech Coalition Board of Directors is issuing this statement to clarify and update the industry on its...

PASS Advisory: Mycoplasma Genitalium

FSC-PASS has been made aware of a sexually transmitted infection (STI), Mycoplasma genitalium, that is rarely tested for in the US but may be increasing in prevalence. Given the available data and screening guidelines from the CDC and other institutions, we do not at...

ALERT: HIV POSITIVE TEST IN EUROPE

The Free Speech Coalition has learned of a confirmed positive test for HIV in Spain. The performer had never tested within the PASS database. Unlike shoots in the US and Canada, productions in Europe do not currently have access to a standardized and unified system...

Industry Alert: Forged Test

FSC has been alerted that a performer previously using the stage name Zae Eden attempted to work using a forged test, digitally manipulated in PDF form. The fraud was discovered when another performer attempted to verify the test in the PASS database. We are now aware...

read more

FSC-PASS ON THE ANTIBODY TEST

FSC-PASS was glad to hear that TTS has chosen to include a free antibody testing panel to their gold standard panel. FSC-PASS had previously evaluated this antibody test, but found it offered no additional risk reduction for performers, while increasing costs for...

read more

Archives

Pin It on Pinterest

Share This